Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Trading 856% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 8.2% — below-average profitability
- Revenue growing at 16% annually
Camtek Ltd. (CAMT) is a Healthcare company operating in Optical Instruments & Lenses, listed on the NASDAQ , with a market capitalisation of $8.0 billion . Key value metrics: P/E ratio 158.2, P/B ratio 13.00, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Camtek Ltd. — Fundamental Analysis Summary
Camtek Ltd. (CAMT) is currently trading 856% above its Graham Number of $18.31, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 158.2x.
On financial health, CAMT shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 8.2% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.56.
StockPik's composite Value Score for CAMT is 37/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CAMT reports a solid gross margin of 50.5% (sector average: 33.5%) and a strong operating margin of 25.8%.
CAMT shows revenue growing at 16% year-over-year, with earnings declining at 57%.